Literature DB >> 8863800

Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivity.

L A van Vliet1, P G Tepper, D Dijkstra, G Damsma, H Wikström, T A Pugsley, H C Akunne, T G Heffner, S A Glase, L D Wise.   

Abstract

A series of 2-aminotetralins, substituted with a methoxy or a hydroxy group on the 5- or 7-position, and with varying N-alkyl or N-arylalkyl substituents, were prepared and evaluated in binding assays for human dopamine (DA) D2, D3, and D4 receptors. Some members of this series were prepared in former studies, but were never tested in vitro with single receptor subtypes, and these were examined again. None of the tested 2-aminotetralins showed high affinity for the dopamine D4 receptor. However, a number of the 2-aminotetralins showed high affinity for both the D2 and the D3 DA receptors, as exemplified by compounds 11-15 and 21-26, while some had a reasonable selectivity for the DA D3 receptors. The affinities of the 2-aminotetralins for the D21, receptor depended on the type of radioligand (agonist or antagonist) used. The agonist affinity data, obtained by using the agonist ligand [3H]N-0437, are thought to be more relevant for calculating DA receptor subtype selectivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863800     DOI: 10.1021/jm960345l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.

Authors:  Jogeshwar Mukherjee; Cristian C Constantinescu; Angela T Hoang; Taleen Jerjian; Divya Majji; Min-Liang Pan
Journal:  Synapse       Date:  2015-10-15       Impact factor: 2.562

2.  PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.

Authors:  Jogeshwar Mukherjee; Divya Majji; Jasmeet Kaur; Cristian C Constantinescu; Tanjore K Narayanan; Bingzhi Shi; Mohamed T Nour; Min-Liang Pan
Journal:  Synapse       Date:  2016-11-30       Impact factor: 2.562

3.  An MCASE approach to the search of a cure for Parkinson's Disease.

Authors:  Gilles Klopman; Aleksandr Sedykh
Journal:  BMC Pharmacol       Date:  2002-04-02

4.  Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging.

Authors:  Neema Pithia; Neal Gulati; Suresh Pandey; Robert Coleman; Ritu Kant; Jogeshwar Mukherjee
Journal:  Nucl Med Biol       Date:  2013-04-04       Impact factor: 2.408

Review 5.  Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson's Disease.

Authors:  Abdeslam Chagraoui; Giuseppe Di Giovanni; Philippe De Deurwaerdère
Journal:  Biomolecules       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.